More than one-third of cancer cases are preventable, massive study finds

Summary
A large global analysis, published in Nature Medicine, estimates that about 38% (roughly 7.1 million) of the 18.7 million new cancer cases in 2022 were attributable to modifiable risk factors. The study examined 36 cancer types across 185 countries and assessed 30 established, changeable risks — including tobacco smoking, infections and alcohol consumption — using exposure data from 2012 combined with 2022 case counts.
Tobacco was the top contributor (around 15% of preventable cases), followed by infections (10%) and alcohol (3%). Lung, stomach and cervical cancers together account for nearly half of the preventable burden. The authors argue that reducing exposure to these risks is one of the most powerful ways to cut future cancer incidence worldwide.
Key Points
- Approximately 38% of new global cancer cases in 2022 were attributable to modifiable risk factors (about 7.1 million cases).
- Tobacco smoking was the largest single contributor to preventable cancers, responsible for about 15% of preventable cases.
- Infections (for example HPV, hepatitis) accounted for roughly 10% of preventable cancers, highlighting the role of vaccination and treatment programmes.
- Alcohol consumption contributed around 3% of preventable cases, and remains an important, addressable risk factor.
- Lung, stomach and cervical cancers make up nearly half of all cases that could be prevented by tackling modifiable risks.
- The study combined exposure data (2012) with 2022 incidence across 185 countries to estimate attributable fractions for 36 cancer types.
Context and relevance
This study gives a contemporary, global estimate of cancer cases linked to changeable causes rather than deaths alone, filling a gap in previous research. It emphasises the continued global health importance of tobacco control, infection prevention (including vaccines), and reducing harmful alcohol use. The findings are relevant to public-health policymakers, clinicians, and prevention programmes because they quantify where interventions could have the biggest impact on reducing future cancer incidence.
Why should I read this?
Look, this isn’t doomscroll fodder — it’s practical. The study shows that a big chunk of cancer is preventable if we act on obvious, modifiable risks. If you work in health policy, public health, or just care about realistic ways to cut cancer rates, the numbers here tell you where to focus time and money.
